Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/179436
Title: Association of Cycling With All-Cause and Cardiovascular Disease Mortality Among Persons With Diabetes
Author: Ried Larsen, Mathias
Rasmussen, Martin Gillies
Blond, Kim
Overvad, Thure F.
Overvad, Kim
Steindorf, Karen
Katzke, Verena
Andersen, Julie L. M.
Petersen, Kristina E. N.
Aune, Dagfinn
Tsilidis, Kostas K.
Heath, Alicia K.
Papier, Keren
Panico, Salvatore
Masala, Giovanna
Pala, Valeria
Weiderpass, Elisabete
Freisling, Heinz
Bergmann, Manuela M.
Verschuren, W. M. Monique
Zamora-Ros, Raul
Colorado Yohar, Sandra M.
Spijkerman, Annemieke M. W.
Schulze, Matthias B.
Ardanaz, Eva M. A.
Andersen, Lars Bo
Wareham, Nick
Brage, Søren
Grøntved, Anders
Keywords: Malalties cardiovasculars
Diabetis
Cardiovascular diseases
Diabetes
Issue Date: 19-Jul-2021
Publisher: American Medical Association (AMA)
Abstract: Importance: Premature death from all causes and cardiovascular disease (CVD) causes is higher among persons with diabetes. Objective: To investigate the association between time spent cycling and all-cause and CVD mortality among persons with diabetes, as well as to evaluate the association between change in time spent cycling and risk of all-cause and CVD mortality. Design, setting, and participants: This prospective cohort study included 7459 adults with diabetes from the European Prospective Investigation into Cancer and Nutrition study. Questionnaires regarding medical history, sociodemographic, and lifestyle information were administered in 10 Western European countries from 1992 through 2000 (baseline examination) and at a second examination 5 years after baseline. A total of 5423 participants with diabetes completed both examinations. The final updated primary analysis was conducted on November 13, 2020. Exposures: The primary exposure was self-reported time spent cycling per week at the baseline examination. The secondary exposure was change in cycling status from baseline to the second examination. Main outcomes and measures: The primary and secondary outcomes were all-cause and CVD mortality, respectively, adjusted for other physical activity modalities, diabetes duration, and sociodemographic and lifestyle factors. Results: Of the 7459 adults with diabetes included in the analysis, the mean (SD) age was 55.9 (7.7) years, and 3924 (52.6%) were female. During 110 944 person-years of follow-up, 1673 deaths from all causes were registered. Compared with the reference group of people who reported no cycling at baseline (0 min/wk), the multivariable-adjusted hazard ratios for all-cause mortality were 0.78 (95% CI, 0.61-0.99), 0.76 (95% CI, 0.65-0.88), 0.68 (95% CI, 0.57-0.82), and 0.76 (95% CI, 0.63-0.91) for cycling 1 to 59, 60 to 149, 150 to 299, and 300 or more min/wk, respectively. In an analysis of change in time spent cycling with 57 802 person-years of follow-up, a total of 975 deaths from all causes were recorded. Compared with people who reported no cycling at both examinations, the multivariable-adjusted hazard ratios for all-cause mortality were 0.90 (95% CI, 0.71-1.14) in those who cycled and then stopped, 0.65 (95% CI, 0.46-0.92) in initial noncyclists who started cycling, and 0.65 (95% CI, 0.53-0.80) for people who reported cycling at both examinations. Similar results were observed for CVD mortality. Conclusion and relevance: In this cohort study, cycling was associated with lower all-cause and CVD mortality risk among people with diabetes independent of practicing other types of physical activity. Participants who took up cycling between the baseline and second examination had a considerably lower risk of both all-cause and CVD mortality compared with consistent noncyclists.
Note: Versió postprint del document publicat a: https://doi.org/10.1001/jamainternmed.2021.3836
It is part of: JAMA Internal Medicine, 2021, vol. 181, num. 9, p. 1196-1205
URI: http://hdl.handle.net/2445/179436
Related resource: https://doi.org/10.1001/jamainternmed.2021.3836
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
jamainternal_riedlarsen_2021.pdf341.77 kBAdobe PDFView/Open    Request a copy


Embargat   Document embargat fins el 19-7-2022


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.